The extensively validated AGE Reader provides an immediate and non-invasive cardiovascular risk prediction. The AGE Reader is very easy to use measurement and therefore leads to clinically valuable extra information.
The AGE Reader dramatically improves the cardiovascular risk prediction for diabetes, renal failure, and atherosclerosis patients. The method is convenient, easy to use and validated.
Read more about cardiovascular risk in:
Would you like to learn more about our products? Request any information you wish to receive here.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.